BioCentury

11:58 PM GMT, Aug 29, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Oxford BioMedica restructures

Gene therapy company Oxford BioMedica (LSE:OXB) said it began a restructuring initiative, which includes a

Read the full 153 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.